CD4 and neoplasm: Moreover, the proportion of Tregs (CD3+CD4+FoxP3+) in the combined treatment group significantly decreased compared to that in the model (p < 0.001) and PDT (p < 0.05) groups, confirming a reduction in tumor-associated immunosuppression (Figures 7F,G).